SWAP-MEAT: Study With Appetizing Plant Food - Meat Eating Alternatives Trial
SWAP-MEAT
1 other identifier
interventional
38
1 country
1
Brief Summary
This study aims to investigate the impact of replacing meat consumption with plant-based meat alternative consumption on cardiovascular health, the gut microbiome, and metabolic status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2018
CompletedFirst Posted
Study publicly available on registry
October 25, 2018
CompletedStudy Start
First participant enrolled
January 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2019
CompletedFebruary 21, 2023
February 1, 2023
11 months
October 23, 2018
February 18, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Trimethylamine N-oxide (TMAO).
Change from baseline in TMAO at 8 weeks.
Baseline and 8 weeks
Secondary Outcomes (12)
Insulin-like Growth Factor-1 (IGF-1)
Baseline and 8 weeks
Microbiota composition
Baseline and 8 weeks
Microbiota function
Baseline and 8 weeks
Total Cholesterol
Baseline and 8 weeks
LDL Cholesterol
Baseline and 8 weeks
- +7 more secondary outcomes
Other Outcomes (8)
Satisfaction with Plant Alternative products
Baseline and 8 weeks
Amount of Plant Alternative product consumption.
Baseline and 8 weeks
Gastrointestinal symptoms
Baseline and 8 weeks
- +5 more other outcomes
Study Arms (2)
Meat Phase first
EXPERIMENTALParticipants will be asked to consume traditional meat products for 8 weeks, then switch to plant-based meat alternative products for another 8 weeks.
Plant Alternative Phase first
EXPERIMENTALParticipants will be asked to consume plant-based meat alternative products for 8 weeks, then switch to traditional meat products for another 8 weeks.
Interventions
Traditional meat products (beef burger patties, pork sausage, etc.)
Plant-based alternatives (The Beyond Burger, Beyond Sausage, etc.)
Eligibility Criteria
You may qualify if:
- Age ≥18
- Meat consumption (beef, pork/sausage, chicken) on average ≥ once a day
- Willing to consume meat (beef, pork/sausage, chicken) ≥ 2 times a day
You may not qualify if:
- Weight \< 110 lb
- BMI ≥ 40
- LDL-C \>190 mg/dL
- Systolic blood pressure (SBP) \> 160 mmHg OR Diastolic blood pressure (DBP) \> 90 mmHg
- Use of any of the following drugs/supplements within the last 2 months:
- systemic antibiotics, antifungals, antivirals or antiparasitics (intravenous, intramuscular, or oral);
- corticosteroids (intravenous, intramuscular, oral, nasal or inhaled);
- cytokines;
- methotrexate or immunosuppressive cytotoxic agents;
- Chronic, clinically significant, or unstable (unresolved, requiring on-going changes to medical management or medication) pulmonary, cardiovascular, gastrointestinal, hepatic or renal functional abnormality, as determined by medical history, Type 1 diabetes, dialysis.
- History of active cancer in the past 3 years except for squamous or basal cell carcinomas of the skin that have been medically managed by local excision.
- Unstable dietary history as defined by major changes in diet during the previous month, where the subject has eliminated or significantly increased a major food group in the diet.
- Recent history of chronic excessive alcohol consumption defined as more than five 1.5-ounce servings of 80 proof distilled spirits, five 12-ounce servings of beer or five 5-ounce servings of wine per day; or \> 14 drinks/week.
- Any confirmed or suspected condition/state of immunosuppression or immunodeficiency (primary or acquired) including HIV infection, multiple sclerosis and Graves' disease.
- Regular/frequent use of smoking or chewing tobacco, e-cigarettes, cigars or other nicotine-containing products.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University
Stanford, California, 94305, United States
Related Publications (2)
Crimarco A, Springfield S, Petlura C, Streaty T, Cunanan K, Lee J, Fielding-Singh P, Carter MM, Topf MA, Wastyk HC, Sonnenburg ED, Sonnenburg JL, Gardner CD. A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: Study With Appetizing Plantfood-Meat Eating Alternative Trial (SWAP-MEAT). Am J Clin Nutr. 2020 Nov 11;112(5):1188-1199. doi: 10.1093/ajcn/nqaa203.
PMID: 32780794BACKGROUNDWard CP, Landry MJ, Cunanan KM, Raphael KL, Dant CC, Gardner CD, Pao AC. Urinary Response to Consuming Plant-Based Meat Alternatives in Persons with Normal Kidney Function: The SWAP-MEAT Pilot Trial. Clin J Am Soc Nephrol. 2024 Nov 1;19(11):1417-1425. doi: 10.2215/CJN.0000000000000532. Epub 2024 Aug 26.
PMID: 39514692DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher D. Gardner, PhD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
October 23, 2018
First Posted
October 25, 2018
Study Start
January 17, 2019
Primary Completion
December 5, 2019
Study Completion
December 5, 2019
Last Updated
February 21, 2023
Record last verified: 2023-02